SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Alphabet's stock is trending as Berkshire Hathaway revealed a significant $4.9B stake, boosting investor confidence. Community discussions revolve around the implications of Buffett's investment and Google's AI prospects. This news, combined with AI demand and cloud momentum, positions $GOOG for continued growth in the tech sector.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell is trending amid speculation around its involvement in a potential TikTok deal and positive sentiment stemming from analysts highlighting its AI server business and long-term growth potential. Community discussions revolve around the company's undervaluation, its relationship with key partners, and the anticipation of new highs, despite some mixed reactions to recent price action. Upgraded financial outlook and EPS growth projections are also fueling investor interest.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is currently trending as the community debates its next move after recent price volatility, with some anticipating a bounce and others bracing for further declines. Discussions include technical analysis around key support levels and whether institutional involvement will stabilize the price. Broader narratives involve comparing Bitcoin's performance against other asset classes and speculation about potential market catalysts.

Sigma Lithium Corp. engages in the producing of a lithium property. It focuses its project in Minas Gerais. The firm also plans to build a world-class commercial-scale lithium concentration plant. The company was founded on June 8, 2011 and is headquartered in Sao Paulo, Brazil.

Sigma Lithium Corporation

Sigma Lithium ($SGML) is trending as investors digest recent Q3 earnings reports and insider buying activity, while lithium prices show signs of recovery. The community is weighing the company's financial health, production capacity, and potential for a price surge amidst broader discussions about the lithium market's future and potential takeover scenarios. Bullish sentiment is building, driven by rising lithium prices and the anticipation of future earnings reports.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategy (MSTR) is trending as investors digest news of significant Bitcoin purchases, potentially leaked ahead of the official announcement, which has sparked debate about the company's valuation relative to its Bitcoin holdings and overall strategy. Community chatter revolves around whether MSTR is undervalued, overleveraged, or simply a leveraged play on Bitcoin, with some expressing concerns about debt and potential risks, while others see it as a buying opportunity. Recent price action has also drawn attention, as MSTR's correlation with Bitcoin and its potential for a short squeeze fuels speculation.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

GOOGL is trending as investors react to Berkshire Hathaway's newly disclosed stake, signaling confidence in Alphabet's AI future and data center investments. The community is buzzing about potential all-time highs and comparing the stock's valuation to other tech giants, while some caution against overbought conditions and the lack of immediate news catalysts. Google's AI leadership and reasonable PE ratio are key talking points, with many eyeing a move towards $300.

Zymeworks, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Its product includes Zanidatamab, which is a novel bispecific antibody that targets two distinct domains of the human epidermal growth factor receptor 2 (HER2). Zanidatamab's unique binding properties result in multiple mechanisms of action that may enable it to address unmet need in patient populations with HER2-expressing cancers. The company was founded on September 8, 2003 and is headquartered in Middletown, DE.

Zymeworks BC Inc

Zymeworks Inc

ZYME is trending due to promising trial results in metastatic breast cancer, sparking community excitement and discussions about its potential.  The strong results have led to speculation about potential acquisitions and partnerships, with some suggesting a platform play rather than a single asset focus.  Additionally, options activity and analyst ratings are contributing to the increased attention on ZYME.

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Strike Coin

Starknet ($STRK) is trending due to increased staking, incentives for BTCFi, and the potential for scaling privacy solutions. Community members are discussing its relationship to ZCash ($ZEC) and the possibility of a "Ztarknet", which would integrate privacy and scalability. The recent surge in staking and new developments in BTCFi are driving renewed interest in the token.

WeShop Holdings Ltd. engages in providing a shoppable social network. It offers shopping in fashion and accessories, health and beauty, home and DIY, food and drink, travel and holidays, tech and electronics, and other popular categories. It includes a library of shoppable product reviews from a digital online shopping mall on mobile devices. The company was founded by John Garner on September 21, 2012 and is headquartered in Jersey, the United Kingdom.

WeShop Holdings Ltd - Ordinary Shares - Class A

Wasatch Pharmaceutical Inc

Wasatch Pharmaceutical (WSHP) is trending due to its recent direct listing, sparking significant community discussion around potential trading opportunities. The stock's volatile price action and potential for a large percentage move are key talking points. Traders are actively monitoring the stock for entry points and potential shorting opportunities amid the heightened activity.

To honor the incredible bravery of Daboo, a heartfelt movement has been created to keep his memory alive The initiative celebrates Daboo's unwavering loyalty and courage while promoting causes that align with his heroic spirit, such aS animal rescue efforts, shelter funding, and pet safety awareness Through storytelling, Daboo's legacy serves as a reminder of the selfless love that animals offer to humans. By sharing his story and supporting these meaningful causes, the memory of Daboo continues to inspire kindness and compassion, ensuring his heroic act is never forgotten No Rug Pulls, No Get Rich Scams. Just Pure love for the meme coins!

Daboo

DABOO is trending amid community discussions about its potential and comparisons to other projects. Some users are expressing concerns about spam and the legitimacy of the project, while others highlight its supply and potential AI applications. The coin is also being mentioned alongside other cryptocurrencies like BTC, SOL, and ETH.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Niagen Bioscience Launches Tru Niagen Beauty The First NAD+ Skincare Supplement in the U.S. Featuring Niagen (Patented Nicotinamide Riboside)

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the launch of Tru Niagen Beauty...

Niagen Bioscience Announces Results from First-Ever Randomized Controlled Trial Exploring Niagen (Patented Nicotinamide Riboside, NR) Supplementation in Long COVID

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today shared promising results from the...

Q2 EPS Estimate for Niagen Bioscience Raised by Analyst

Niagen Bioscience, Inc. (NASDAQ:NAGE - Free Report) - Research analysts at Roth Capital raised their Q2 2026 EPS estimates for shares of Niagen Bioscience in a research note issued to investors on...

Niagen Bioscience (NASDAQ:NAGE) Shares Gap Up After Better-Than-Expected Earnings

Niagen Bioscience (NASDAQ:NAGE) Shares Gap Up on Earnings Beat...

Niagen Bioscience Announces $10 Million Share Repurchase Program

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that its Board of Directors has...

Niagen Bioscience (NAGE) Surpasses Q3 Earnings and Revenue Estimates

Niagen Bioscience (NAGE) delivered earnings and revenue surprises of +150.00% and +8.58%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Niagen Bioscience, Inc. Reports Third Quarter 2025 Financial Results and Reaffirms Increased Full Year Outlook

Niagen Bioscience, Inc. (NASDAQ:NAGE) today announced financial results for the third quarter of 2025. Third Quarter 2025 Financial Highlights Compared to Prior Year Period Total net sales increased...

Earnings Preview: Recursion Pharmaceuticals (RXRX) Q3 Earnings Expected to Decline

Recursion Pharmaceuticals (RXRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Niagen Bioscience (NAGE) Reports Next Week: What to Expect

Niagen Bioscience (NAGE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Niagen Bioscience to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, announces that it will hold a conference call on...

Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). The company’s patent portfolio includes Nicotinamide Riboside (NR) and other NAD+ precursors, which are commercialized as the flagship ingredient Niagen. It operates through the following segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the firm’s proprietary ingredients directly to consumers as well as to distributors. The Ingredients segment supplies ingredients as raw materials to the manufacturers of consumer products. The Analytical Reference Standards and Services segment includes supply of phytochemical reference standards and other research and development services. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in 1999 and is headquartered in Los Angeles, CA.

Niagen Bioscience Inc.

Will NVIDIA ($NVDA) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$6.81
Prev Close	$6.99
Open	$6.86
Dividend Yield	0.00%
50-Day Moving Average	$8.10
Beta	1.39
Avg. Volume	1.21M
PE Ratio	28.23

52-Week High	$14.69
52-Week Low	$5.16
Market Capitalization	$548.27M
EPS (Annual)	$0.1094
Price to Book	7.74
Revenue Per Employee	$957,663.46
Enterprise Value/EBITDA	N/A

NAGE
Niagen Bioscience Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NAGE News

NAGENiagen Bioscience Inc.